ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 1,512,800 | $200,672,899 | 2.58% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 12, 2025 |
| June 30, 2025 | 1,491,339 | $202,836,995 | 2.60% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 8, 2025 |
| Sept. 30, 2025 | 1,467,147 | $196,509,648 | 2.42% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 3, 2025 |
| Dec. 31, 2025 | 1,458,381 | $182,720,528 | 2.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 1,452,736 | $149,152,418 | 1.92% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 1,452,342 | $131,785,524 | 1.62% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 3, 2026 |
| Sept. 30, 2026 | 1,448,683 | $143,173,352 | 1.69% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 28, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.